Evidence map›Paper›PMID 36288571›Full record

ArticleJournal of the American Chemical Society2022

Enantioselective Synthesis of

Caitlin R Lacker, Travis J DeLano, Emily P Chen, Jongrock Kong, Kevin M Belyk, Tiffany Piou, Sarah E Reisman

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Enantioselective C(spAccounts of chemical research · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Caitlin R LackerThe Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States.ORCID 0000-0003-2531-2636
Travis J DeLanoThe Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States.ORCID 0000-0002-2052-611X
Emily P ChenThe Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States.ORCID 0000-0002-6603-9886
Jongrock KongDepartment of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.ORCID 0000-0003-1509-687X
Kevin M BelykDepartment of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.ORCID 0000-0003-1585-0430
Tiffany PiouDepartment of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.ORCID 0000-0003-4923-9138
Sarah E ReismanThe Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States.ORCID 0000-0001-8244-9300

Funding

Chemical Synthesis of Chiral Bioactive MoleculesR35GM118191 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI Sarah Elizabeth Reisman · 2016 to 2026
$6.6M
NIGMS NIH HHS R35 GM118191
6 · The paper itself

Abstract

An asymmetric cross-coupling of α-

Indexed as

BromidesNickelCatalysisLigandsMolecular StructureStereoisomerismBromidesLigandsNickel

Identifiers

PMID36288571
PMCPMC10326726

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.